Biotech buys intellect
April 6, 2016
BIOTECH Capital Limited has
released an ASX announcement
that it has acquired 100% of
the current share capital in
Biointelect Pty Ltd as part of the
company’s strategy of making
active investments in life science
businesses that have strong growth
potential and will benefit from
greater access to development
capital.
Biointelect, established in 2011
by Jennifer Herz, is a Sydney based
advisory firm providing
a range of development and
commercialisation services for local
and international companies in the
biotechnology, medical device and
pharmaceutical industry.
Services provided by Biointelect
include clinical, regulatory, market
evaluation, reimbursement
strategies and partnering advice,
the announcement said.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Apr 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Apr 16
